Elevated expression of DLK1 was reported in neuroblastoma from patients with poor outcome (62) and induction of DLK1 expression in lung cancer activated both notch-dependent signaling and upregulated matrix metalloproteinase MMP9, which increased cellular invasive potential (63). The gene discussed is MMP9; the disease is neuroblastoma.